Affinia Therapeutics to Present New Data on its AFTX-201 Program in BAG3 Dilated Cardiomyopathy, BBB-Penetrant AAV Capsids, and Proprietary Manufacturing Technology at the 28th Annual American Society of Gene & Cell Therapy 2025 Annual Meeting
Company’s lead program, AFTX-201 in BAG3 dilated cardiomyopathy, on track for IND submission fourth quarter of 2025 with potential initial readouts of clinical... Read more.
Teradyne Reports First Quarter 2025 Results
Revenue towards the high end and earnings above Q1 guidance ranges Revenue of $686 million in Q1’25, up 14% from Q1’24 Strong year-over-year growth... Read more.
WM Announces First Quarter 2025 Earnings
Strong Operational Performance Combined with WM Healthcare Solutions Results Deliver Outsized Growth WM Adds Two Recycling Automation Projects in Key Markets During... Read more.
Evolv Technology Completes Restatement of Previously Issued Financial Statements and Reports Third Quarter, Fourth Quarter and Full Year 2024 Financial Results
— Company Regains Compliance with SEC Reporting and NASDAQ Listing Requirements — — Company Achieves Positive Adjusted EBITDA1 in Q4’24... Read more.
Calix Announces Upcoming Investor Events
SAN JOSE, Calif.–(BUSINESS WIRE)–Calix, Inc. (NYSE: CALX) today announced that Calix management will participate in the upcoming investor events: Event:... Read more.
NRC Health Announces First Quarter Results
LINCOLN, Neb.–(BUSINESS WIRE)–National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2025 and other... Read more.
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
100% of resectable Stage I-IV colorectal cancer relapses were detected ahead of imaging, with 87% of those relapses having been detected in the first eight weeks... Read more.
IFF Pharma Solutions to Showcase Portfolio at Excipient World 2025
Sustainability Expert Will Share Key Insights on Industry-Leading Solutions for Improving Environmental Impact NEW YORK–(BUSINESS WIRE)–IFF (NYSE: IFF)... Read more.
Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting
Presentation will highlight examples of successful surveillance and treatment of HLH in the context of gene therapy NEW YORK–(BUSINESS WIRE)–Neurogene... Read more.
Chain Bridge Bancorp, Inc. Reports First Quarter 2025 Financial Results
MCLEAN, Va.–(BUSINESS WIRE)–Chain Bridge Bancorp, Inc. (NYSE: CBNA) (the “Company”), the holding company for Chain Bridge Bank, N.A. (the... Read more.